Can colloidal gold help with anxiety? It is a compelling question, especially because gold nanoparticles are increasingly studied in neuroscience and drug delivery.
For the broader evidence picture beyond anxiety research, read our research guide to colloidal gold benefits.
But the evidence is much more preliminary than many wellness articles suggest.
A 2025 rat study reported reduced anxiety-like behaviour at one tested gold-nanoparticle dose. Other animal experiments have produced very different findings, including increased anxiety-like behaviour, altered neurotransmitters and oxidative-stress markers. These studies used specific engineered particles, doses and administration routes rather than an ordinary consumer colloidal-gold routine.
There are currently no robust human clinical trials showing that consumer colloidal gold treats anxiety or an anxiety disorder.
This guide looks at the encouraging findings, the contradictory findings and the gap between experimental nanomedicine and commercial colloidal gold.
Quick Answer: Does Colloidal Gold Reduce Anxiety?
There is not enough human evidence to say that colloidal gold reduces anxiety.
The most direct positive research currently comes from animal studies of engineered gold nanoparticles. In a 2025 study of 35 male Wistar rats, one tested AuNP dose was associated with reduced induced anxiety-like behaviour. However, other mouse studies have reported anxiety-like effects or increased anxiety following different nanoparticle formulations and exposure conditions.
That pattern tells us something important: gold nanoparticles are biologically active, and their effects can change with particle design, dose, coating, timing and route of administration. It does not establish a general calming effect for “gold”.
What Is Colloidal Gold?
Colloidal gold is a liquid dispersion containing very small particles of elemental gold. Depending on particle size and concentration, a gold colloid may appear ruby red because nanoscale gold interacts with light through surface plasmon resonance.
That optical property helps explain colour. It does not tell us whether a product crosses the blood-brain barrier, alters neurotransmitters or affects anxiety.
Particle size matters, but so do surface coating, aggregation state, dose, charge, biological environment and administration route. A laboratory nanoparticle injected into a rodent cannot automatically be treated as equivalent to an orally consumed commercial colloidal product.
For the product-category basics, see What Is Colloidal Gold?.
The 2025 Rat Study: The Most Direct Positive Anxiety Finding
A 2025 study published in IBRO Neuroscience Reports investigated gold nanoparticles in 35 male Wistar rats. Researchers used behavioural tests including the open-field test and elevated maze to examine anxiety-like behaviour, and other tasks to assess learning and memory.
The authors reported that:
- a tested AuNP concentration of 100 μg/ml reduced induced anxiety-like behaviour compared with control;
- higher tested concentrations were associated with changes in learning and memory measures; and
- the authors proposed that AuNPs deserved further investigation for neurological applications.
This is relevant research, but it remains preclinical. Rat behaviour tests are useful experimental models, not a diagnosis of human anxiety. The study does not establish an effective human dose and does not test Gold Healing or another retail colloidal-gold product.
Why One Positive Animal Study Is Not the Whole Story
If gold nanoparticles had a simple, universal anti-anxiety effect, we would expect other experiments to point consistently in the same direction. They do not.
Transferrin-Conjugated Gold Nanoparticles
A 2023 mouse study examined bare gold nanoparticles and transferrin-conjugated gold nanoparticles. The researchers reported behavioural changes consistent with an anxiety-like effect in the transferrin-conjugated group and concluded that neurobiological effects should be characterised before medical use.
Chronic Oral Exposure During Pregnancy and Lactation
Another study investigated chronic oral gold-nanoparticle exposure in mice during pregnancy and lactation. Gold was detected beyond the blood-brain barrier, but offspring did not show improved spatial memory and showed increased anxiety levels.
Brain Oxidative Stress and Neurotransmitters
An earlier rat study using injected 20 nm AuNPs reported oxidative-stress markers, DNA-damage-related markers and decreases in dopamine and serotonin in brain tissue.
These studies are not directly comparable because their particles and experimental designs differ. That is exactly the point: “gold nanoparticles” is not one biologically uniform intervention.
What About Gold Nanoparticles Combined With Sertraline?
A 2023 mouse study investigated gold nanoparticles associated with the antidepressant sertraline in a model involving anxiety-like behaviour and neuroinflammatory changes.
The combination produced sex-dependent and brain-region-specific effects and improved some outcomes compared with the experimental model. This is interesting for nanomedicine because gold particles can potentially be engineered as carriers or modifiers of other drugs.
It is not evidence that colloidal gold alone acts like sertraline, boosts antidepressant treatment in humans or should be combined with psychiatric medication.
Drug-nanoparticle systems are deliberately engineered pharmaceutical technologies. They should not be used as a shortcut for claims about retail colloidal gold.
Can Gold Nanoparticles Cross the Blood-Brain Barrier?
Some engineered gold nanoparticles can reach brain tissue under certain experimental conditions. But “gold crosses the blood-brain barrier” is too broad to be useful on its own.
Brain exposure depends on factors including:
- particle size;
- surface coating and functionalisation;
- charge;
- aggregation state;
- dose;
- route of administration; and
- the physiological state of the blood-brain barrier.
Researchers often attach molecules such as transferrin specifically to influence delivery. That is very different from assuming that every nanoparticle in an orally consumed colloid will “cross the BBB effectively”.
Our broader evidence review is available in Colloidal Gold and the Brain: What Does the Science Say?.
Does Inflammation Explain Anxiety?
Research into anxiety increasingly considers interactions between stress systems, immune signalling, neuroinflammation, genetics, sleep, environment and neurotransmission. But anxiety disorders are not simply an “inflammation problem”.
Gold nanoparticles have been studied for inflammatory and oxidative pathways in a variety of laboratory and animal models. Those findings can help researchers investigate mechanisms, but they do not establish that taking colloidal gold reduces anxiety by “calming brain inflammation”.
Mechanistic plausibility is the beginning of a research question, not proof of a consumer benefit.
Does Gold Improve Serotonin, Dopamine or GABA?
The current evidence does not support a simple claim that colloidal gold “balances” serotonin, dopamine or GABA in humans.
In fact, experimental AuNP studies have produced differing neurochemical effects depending on the system being studied. One rat toxicology experiment reported decreases in dopamine and serotonin after a specific injected nanoparticle exposure.
This is why statements such as “gold naturally improves neurotransmitter balance” go beyond the available evidence.
What Human Evidence Exists?
Gold nanoparticles and gold nanocrystals have entered human research in areas such as oncology, imaging, drug delivery and investigational neurological medicine. That shows genuine clinical interest in engineered gold technologies.
But those programmes do not provide a human anxiety trial.
A 2026 study also directly characterised commercially available oral colloidal-gold supplements. It confirmed that the tested products contained metallic gold nanoparticles and explored preliminary biological properties. It did not test anxiety, stress, mood or emotional resilience.
So there remains a significant evidence gap between:
“gold nanoparticles can interact with biological systems”
and
“drinking colloidal gold reduces human anxiety”.
What About the Pineal Gland and “Inner Calm”?
The pineal gland produces melatonin and helps coordinate circadian rhythm. Sleep disruption can also make anxiety harder to manage.
However, current evidence does not show that colloidal gold prevents pineal calcification, decalcifies the gland or increases melatonin in humans.
If you are interested in that topic, see Decalcifying the Pineal Gland: What Does Science Actually Show?.
How Does This Compare With Established Anxiety Support?
For people experiencing persistent anxiety, established support has a much stronger human evidence base than colloidal gold.
The NHS identifies approaches including:
- cognitive behavioural therapy and other talking therapies;
- guided self-help;
- regular exercise;
- sleep support;
- relaxation and breathing techniques; and
- medicines such as SSRIs when clinically appropriate.
Adults in England can also self-refer to NHS Talking Therapies in many areas.
That does not prevent someone from having a personal wellness ritual. It simply puts the evidence in the right order: colloidal gold has not been established as an anxiety treatment and should not replace proven mental-health care.
For NHS information, see Generalised anxiety disorder.
Colloidal Gold and Anxiety: Claims vs Evidence
| Claim | What the evidence supports |
|---|---|
| Gold nanoparticles can affect anxiety-like behaviour | Yes, in animal experiments, but results vary by formulation and exposure. |
| AuNPs reduced anxiety-like behaviour in a 2025 study | Yes, at one tested dose in male rats. |
| All AuNP studies show a calming effect | No. Other animal studies have reported anxiety-like or adverse neurobiological effects. |
| Gold nanoparticles can sometimes reach brain tissue | Yes, depending on particle design, dose and route. |
| Any consumer colloidal gold automatically crosses the BBB | Not established. |
| Colloidal gold balances serotonin or dopamine in humans | Not demonstrated in clinical trials. |
| Colloidal gold treats anxiety disorders | No robust human clinical evidence establishes this. |
| Talking therapies such as CBT can treat anxiety | Yes. These are established, evidence-based treatments used by the NHS. |
Key Takeaways
- A 2025 rat study reported reduced anxiety-like behaviour at one gold-nanoparticle dose.
- Other animal studies have reported increased anxiety-like behaviour or adverse neurochemical effects.
- Particle size, coating, dose and route can materially change AuNP behaviour.
- Experimental BBB penetration does not prove that a retail colloidal-gold product reaches the human brain in a therapeutically meaningful amount.
- There are no robust human trials showing that consumer colloidal gold treats anxiety.
- The 2026 study of commercial colloidal-gold supplements did not test mood or anxiety outcomes.
- Established anxiety treatments such as CBT and NHS Talking Therapies have much stronger human evidence.
Frequently Asked Questions
Can colloidal gold help anxiety?
There is currently no robust human clinical evidence showing that colloidal gold treats anxiety. Animal studies of engineered gold nanoparticles have produced mixed results.
Was gold shown to reduce anxiety in rats?
Yes. A 2025 study of 35 male Wistar rats reported reduced induced anxiety-like behaviour at one tested AuNP concentration. That preclinical result cannot be assumed to apply to humans or commercial colloidal gold.
Have gold nanoparticles ever increased anxiety?
Yes. Other mouse studies using different nanoparticle designs and exposure conditions have reported anxiety-like behaviour or increased anxiety, illustrating that AuNP effects are not uniform.
Does colloidal gold cross the blood-brain barrier?
Some engineered AuNPs reach brain tissue in experimental models, but BBB transport depends on particle design, dose and route. It should not be assumed for every consumer product.
Does colloidal gold increase serotonin?
There is no established human evidence that colloidal gold increases serotonin. Experimental nanoparticle studies have reported different neurochemical effects depending on their design.
How quickly does colloidal gold work for anxiety?
No evidence-based onset time exists because colloidal gold has not been established as an anxiety treatment in human clinical trials.
Can colloidal gold replace anxiety medication or therapy?
No. Colloidal gold is not an established treatment for anxiety disorders. Evidence-based treatments include talking therapies such as CBT and, when appropriate, medicines prescribed by a healthcare professional.
References
- Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats. IBRO Neuroscience Reports. 2025. PubMed PMID 40893782.
- Yavuz Y, et al. Investigation of effects of transferrin-conjugated gold nanoparticles on hippocampal neuronal activity and anxiety behavior in mice. Molecular and Cellular Biochemistry. 2023. PubMed PMID 36574097.
- Impact of Chronic Oral Administration of Gold Nanoparticles on Cognitive Abilities of Mice. 2023. PubMed PMID 37240304.
- Identification of potential biomarkers of gold nanoparticle toxicity in rat brains. 2012. PubMed PMID 22691312.
- Abelaira HM, et al. Sertraline associated with gold nanoparticles reduce cellular toxicity and induce sex-specific responses in behavior and neuroinflammation biomarkers in a mouse model of anxiety. Pharmacology Biochemistry and Behavior. 2023. PubMed PMID 37879445.
- Physicochemical characterization and preliminary biological assessment of commercially available colloidal gold dietary supplements. 2026. PubMed PMID 42450145.
- NHS. Generalised anxiety disorder (GAD). NHS guidance.
